BRIEF-Alvotech SA Says Study Shows Equivalence And Safety Of AVT23 To Xolair

Reuters
Jun 25
BRIEF-<a href="https://laohu8.com/S/ALVO">Alvotech</a> SA Says Study Shows Equivalence And Safety Of AVT23 To Xolair

June 25 (Reuters) - Alvotech SA ALVO.O:

  • POSITIVE TOP LINE RESULTS FROM CONFIRMATORY EFFICACY STUDY FOR PROPOSED BIOSIMILAR TO XOLAIR® (OMALIZUMAB)

  • ALVOTECH SA - STUDY SHOWS EQUIVALENCE AND SAFETY OF AVT23 TO XOLAIR

  • ALVOTECH SA - MAA FILING WITH EMA EXPECTED BEFORE YEAR-END

Source text: ID:nGNX3FXcL3

Further company coverage: ALVO.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10